Delivery Order SPE2DB20D1109-SPE2DB25FP51X
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $4.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for PROLIA 60 mg/mL syringes valued at $13,150.17 by the Defense Logistics Agency on September 16, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a non-competitive award issued under an existing contract vehicle. The award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and fulfills...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 15, 2025, for Prolia 60 mg/mL syringes valued at $12,957.22. The contract employs firm fixed pricing with an ultimate completion date of September 16, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp was awarded a $57,441.34 delivery order by the Defense Logistics Agency (DLA) on August 1, 2025, for the supply of Prolia 60 mg/mL syringes. This firm fixed-price, non-set-aside contract is scheduled for completion by August 4, 2025, with fulfillment taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a purchase of pharmaceutical supplies supporting federal medical procurement needs, primarily for military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Prolia 60 mg/mL syringes, valued at $11,629.70. This is a firm fixed price delivery order with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child order under a larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,601.60 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Prolia 60 mg/ml syringes. The contract is not set-aside and operates under a firm fixed-price delivery order model, with performance to be completed by July 15, 2025, at the vendor's Conshohocken, Pennsylvania facility. This award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $26,999.75 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Prolia 60 mg/ml syringes. This firm fixed price contract is non-competitive with no set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $33,324.63 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $30,977.33 for Prolia 60 mg/ml syringes on June 2, 2025, with a completion date of June 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment of pharmaceutical supply needs under an existing contract vehicle. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $19,310.96 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 9, 2025. AmerisourceBergen will perform the work from its corporate office in Conshohocken, Pennsylvania, serving as a critical pharmaceutical supplier within the federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $14,539.96 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with...